2018-05-15T12:56:25-05:00 2017-06-30 366055558 GRANT THORNTON LLP 200 S ORANGE AVENUE SUITE 2050 ORLANDO FL 32801 990 2016-07-01 592451713 H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 YVETTE M LYONS TREMONTI EVP/CFO 8137457862 2018-05-14 1 MICHELE N MELCHIOR P00488037 4074815100 2016 2022-09-23 18:48:47Z ALAN F LIST MD 12902 MAGNOLIA DRIVE TAMPA FL 33612 226961351 0 X WWW.MOFFITT.ORG X 1984 FL TO PROMOTE AND SUPPORT THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 22 21 1981 459 2777129 2544390 132852458 142592916 2221956 5529176 5334488 2486427 4000506 2668597 144409408 153277116 757818 888196 0 0 90029311 102893642 0 0 0 67174881 71129130 157962010 174910968 -13552602 -21633852 778289227 875561050 389321274 427646396 388967953 447914654 X SEE SCHEDULE OTO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 0 0 122218391 888196 4395110 SEE SCHEDULE OTHE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS A RECOGNIZED LEADER IN FOCUSED, INNOVATIVE CANCER RESEARCH, A MAJOR REGIONAL ONCOLOGY REFERRAL CENTER, AND A NATIONAL CANCER INSTITUTE DESIGNATED COMPREHENSIVE CANCER CENTER.BASED ON ITS SINGULAR MISSION - TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER - THE CANCER CENTER'S RESEARCH ACTIVITIES RELATE PRIMARILY TO THE AREAS OF BASIC SCIENCE, CANCER PREVENTION AND CONTROL, TRANSLATIONAL SCIENCE, PRE-CLINICAL AND CLINICAL INVESTIGATIONS, AND PROVIDING MANAGEMENT AND OTHER SUPPORT SERVICES AS THE SOLE CORPORATE MEMBER AND PARENT FOR THE FOLLOWING SUBSIDIARY CORPORATIONS: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. (THE HOSPITAL) WHICH PROVIDES MEDICAL AND HOSPITAL CARE, MEDICAL EDUCATION AND TRAINING, AND CLINICAL (PATIENT-RELATED) RESEARCH IN MAINTAINING HEALTH, AND PREVENTING, DETECTING, AND TREATING CANCER;H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. (MOFFITT MEDICAL GROUP) WHICH EMPLOYS AND MANAGES PHYSICIANS AND OTHER MEDICAL PROFESSIONALS WHO STAFF THE HOSPITAL, AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER; ANDH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. (THE FOUNDATION) WHICH IS THE PRINCIPAL FUND-RAISING ORGANIZATION FOR THE CANCER CENTER AND ITS SUBSIDIARIES.THE CANCER CENTER'S MULTIDISCIPLINARY CLINICAL PROGRAM STRUCTURE AND OPEN LABORATORY ARCHITECTURE PROVIDE AN ENVIRONMENT CONDUCIVE FOR TRAINING FUTURE SCIENTIFIC AND CLINICAL LEADERS IN ONCOLOGY, AND REFLECT THE CANCER CENTER'S COMMITMENT TO COLLABORATION IN ALL ASPECTS OF CANCER RESEARCH. 122218391 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 1 1 1 0 0 1 416 0 1 1981 1 1 1 0 0 0 0 0 0 0 0 0 0 X 22 21 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 X YVETTE M LYONS TREMONTI 8137457862 12902 MAGNOLIA DR TAMPA FL 33612 TIMOTHY J ADAMS DIRECTOR, CHAIR 10/2017 1.00 1.00 X X 0 0 0 ROBERT ROTHMAN DIRECTOR, IMMED PAST CHAIR 10/2017 1.00 1.00 X X 0 0 0 SENATOR CONNIE MACK DIRECTOR, IMMED PAST CHAIR TO 9/2017 1.00 1.00 X X 0 0 0 BETH A HOUGHTON DIRECTOR, VICE CHAIR 10/2017 1.00 1.00 X X 0 0 0 BENJAMIN H HILL III ESQ DIRECTOR, SECRETARY/TREASU 1.00 1.00 X X 0 0 0 CARLOS ALFONSO DIRECTOR 1.00 X 0 0 0 ANGELA BIEVER DIRECTOR 1.00 X 0 0 0 THE HONORABLE CARL CARPENTER DIRECTOR 1.00 X 0 0 0 THEODORE J COUCH SR DIRECTOR 1.00 1.00 X 0 0 0 EDWARD DEBARTOLO DIRECTOR 1.00 X 0 0 0 DAN DOYLE DIRECTOR 1.00 X 0 0 0 EDWARD C DROSTE DIRECTOR 1.00 1.00 X 0 0 0 CECELIA D FERMAN DIRECTOR 1.00 X 0 0 0 JUDY L GENSHAFT PHD DIRECTOR 1.00 X 0 0 0 REGINALD GOINS DIRECTOR 1.00 1.00 X 0 0 0 VALERIE GODDARD DIRECTOR 1.00 1.00 X 0 0 0 THE HONORABLE JOHN A GRANT DIRECTOR 1.00 X 0 0 0 THE HONORABLE JAMES T HARGRETT DIRECTOR 1.00 X 0 0 0 THE HONORABLE H LEE MOFFITT DIRECTOR 1.00 4.00 X 0 0 0 JOHN RAMIL DIRECTOR 1.00 X 0 0 0 FRANCISCO SANCHEZ DIRECTOR 1.00 X 0 0 0 LIZ SMITH DIRECTOR 1.00 X 0 0 0 JOHN TOMLIN DIRECTOR 1.00 X 0 0 0 ALAN F LIST PRES/CEO 44.00 11.00 X 1393747 0 143654 LOUIS D DE LA PARTE EVP GEN COUNS & ASST SEC 22.00 33.00 X 583407 0 119002 JOHN A KOLOSKY EVP COO 24.00 31.00 X 910725 0 213791 G DOUGLAS LETSON EVP-PIC 11.00 44.00 X 0 795737 97407 THOMAS A SELLERS EVP CNT DIR, DIR-MRI 55.00 X 812341 0 132310 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREAS 22.00 33.00 X 661436 0 73682 LYNN C MOSCINSKI CHIEF ACADEMIC OFFICER 1.00 54.00 X 0 563753 87786 MARIANA BUGALLO-MUROS VP CHIEF HR OFFICER 55.00 X 385384 0 48964 DONALD FUTRELL VP FACILITIES & SUPPORT SV 55.00 X 301886 0 40427 B LEE GREEN VP DIVERSITY, PR & STRAT COMM 55.00 X 356320 0 64801 JENNIFER GREENMAN VP & CIO 55.00 X 338276 0 57354 DIANE HAMMON VP STRATEGIC DEVELOPMENT 55.00 X 324990 0 65689 TRACY N PETERSON VP DEPUTY GENERAL COUNSEL 55.00 X 280809 0 54004 DANA E ROLLISON VP CHIO 55.00 X 356909 0 71544 BRIAN SPRINGER VP RESEARCH ADMIN 55.00 X 384262 0 38914 W J WILSON VP GOVT RELATIONS 55.00 X 340157 0 70251 KAREN FIELDS MED DIR, STRATEGIC ALLIANC 50.00 X 157427 0 11321 JOHN L CLEVELAND ACD BASIC SCIENCE NFGC 50.00 X 473266 0 49057 JULIE Y DJEU ACD RESEARCH EDUCATION 50.00 X 408245 0 65625 ROBERT J GILLIES PL CHAIR RSCH BASIC SCIENCE-IMAGING 50.00 0.00 X 417603 0 78926 SAID M SEBTI PL CHAIR RSCH BASIC SCIENCE-DRUG DISC 50.00 0.00 X 385823 0 67337 DORTE HEIMBECK FORMER INT VP HR 50.00 X 186873 0 35252 JAMES J MULAY FORMER EVP APPL SC & ACD T 50.00 1.00 X 539491 0 57356 DANIEL M SULLIVAN FORMER EVP ACD CLINICAL IN 0.00 50.00 X 0 613768 73669 WILLIAM S DALTON FORMER PRES-CEO;CTR DIR TO 0.00 55.00 X 0 754180 59062 9999377 2727438 1877185 215 1 1 0 BIRDSALL VOSS & ASSOCIATES 250 W COVENTRY COURT STE 300 MILWAUKEE WI 53217 MARKETING SERVICES 9836732 FREEDOM SOLUTIONS LLC PO BOX 47765 TAMPA FL 33646 IT SERVICES 3527255 SHUMAKER LOOP & KENDRICK LLP 101 E KENNEDY BLVD STE 2800 TAMPA FL 33602 LEGAL SERVICES 2056705 SODEXO 9801 WASHINGTON BLVD GAITHERSBURG MD 20878 FOOD MANAGEMENT SERVICES 1974557 DELOITTE CONSULTING LLP 4022 SELLS DRIVE HERMITAGE TN 37076 CONSULTING SERVICES 1630483 55 19759940 99990103 22842873 1589843 142592916 CORE LAB REVENUE 900099 2458018 2458018 CELL THERAPY PRODUCTS 900099 1484100 1484100 RESEARCH COLLABORATION 900099 1134066 1134066 AFFILIATE SERVICES 900099 179870 179870 CONFERENCE REVENUE 900099 119772 119772 153350 153350 5529176 2494816 2494816 364824 364824 3219 3219 346922 226922 120000 120000 120000 73084100 72746199 711114 337901 -711114 -373213 -373213 PARKING 900099 1004190 1004190 LICENSE FEES 541700 546788 546788 SETTLEMENT 900099 410360 410360 584040 38963 545077 2545378 153277116 3275834 2777129 4631237 X 888196 888196 10543830 1630421 8913409 998584 998584 74523316 58006742 16516574 4163628 2946273 1217355 7580644 5712802 1867842 5083640 3446619 1637021 1519265 1519265 39636 39636 143143 143143 419094 419094 19474215 8310191 11164024 1780875 32237 1748638 15190082 10632469 4557613 4932939 4932939 4709689 1184807 3524882 1657798 1316132 341666 783200 783200 9054045 9054045 80356 80356 ALLOC OF INTERCO EXP 0 18643934 -18643934 SUBCONTRACTS 3570906 3570906 ECONOMIC DEVELOPM-M2GEN 1783396 1783396 CORE LAB EXPENSES 1721043 1721043 4269448 2392223 1877225 174910968 122218391 52692577 0 146542376 169727185 1915239 1564100 13246995 17209009 18564744 11266243 15396275 766701164 388583766 361071127 378117398 500100 500100 243747147 274482239 778289227 875561050 81851647 89541001 7052737 5535911 292164560 324942355 8252330 7627129 389321274 427646396 X 337879742 384452017 51088211 63462637 388967953 447914654 778289227 875561050 X -21633852 7064664 73515889 X 0 1 X 1 1 1 X 93306736 101277491 124702019 132852458 142592916 594731620 93306736 101277491 124702019 132852458 142592916 594731620 594731620 3974245 3911053 2520087 3014450 2859640 16279475 70493 23642 20258 15896 2586085 2716374 2207626 2200564 17397496 3759373 2509634 28074693 641802162 12862134 0.92670 0.92790 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: CIGARETTE TAX PROCEEDS - 2012 AMOUNT: $ 657,163. 2013 AMOUNT: $ 668,365. 2014 AMOUNT: $ 962,301. LICENSE FEES - 2012 AMOUNT: $ 190,434. 2013 AMOUNT: $ 138,078. 2014 AMOUNT: $ 13,859,061. 2015 AMOUNT: $ 282,908. 2016 AMOUNT: $ 546,788. PARKING - 2012 AMOUNT: $ 1,045,114. 2013 AMOUNT: $ 1,093,542. 2014 AMOUNT: $ 1,079,147. 2015 AMOUNT: $ 1,043,690. 2016 AMOUNT: $ 1,004,190. EYE INSTITUTE REIMBURSEMENT - 2012 AMOUNT: $ 148,051. 2013 AMOUNT: $ 138,490. 2014 AMOUNT: $ 143,888. 2015 AMOUNT: $ 127,560. 2016 AMOUNT: $ 146,619. LEASES - 2012 AMOUNT: $ 59,455. 2013 AMOUNT: $ 1,639. 2014 AMOUNT: $ 5,578. 2015 AMOUNT: $ 48,351. 2016 AMOUNT: $ 21,551. STAFF RETAIL SERVICES - 2012 AMOUNT: $ 29,107. 2013 AMOUNT: $ 83,842. 2014 AMOUNT: $ 107,450. 2015 AMOUNT: $ 41,892. 2016 AMOUNT: $ 51,364. SETTLEMENT - 2014 AMOUNT: $ 728,402. 2016 AMOUNT: $ 410,360. SUPPORT ACCOUNTS - 2015 AMOUNT: $ 415,730. 2016 AMOUNT: $ 232,370. REBATES - 2015 AMOUNT: $ 116,048. 2016 AMOUNT: $ 85,728. INTEREST FROM CONTROLLED ORG - 2015 AMOUNT: $ 152,860. PREMIER PARTNERSHIP - 2015 AMOUNT: $ 924,975. REV RECOG OF PRIOR YEAR LIABILITY - 2015 AMOUNT: $ 584,843. ROYALTIES - 2016 AMOUNT: $ 3,219. MISC - 2012 AMOUNT: $ 78,302. 2013 AMOUNT: $ 76,608. 2014 AMOUNT: $ 511,669. 2015 AMOUNT: $ 20,516. 2016 AMOUNT: $ 7,445. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 7298 1 3337 0 1 201335 1 7877 1 5782 225629 0 PART II-B, LINE 1: THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS THREE NON-PROFIT SUBSIDIARY CORPORATIONS ("CORPORATION") WERE CREATED TO GOVERN AND OPERATE THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE ("INSTITUTE") PURSUANT TO SECTION 1004.43, FLORIDA STATUTES. AMONG OTHER THINGS, SECTION 1004.43, FLORIDA STATUTES PROVIDES: (1) THAT THE CORPORATION SHALL ENTER INTO AN AGREEMENT WITH THE STATE BOARD OF EDUCATION FOR THE UTILIZATION OF FACILITIES ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA; (2) THAT THE CORPORATION SUBMIT ANNUAL POST AUDITS OF ITS FINANCIAL ACCOUNTS TO THE AUDITOR GENERAL OF THE STATE OF FLORIDA AND THE BOARD OF GOVERNORS FOR THEIR REVIEW; AND (3) THAT THE CORPORATION'S CEO REPORT TO THE BOARD OF GOVERNORS OR ITS DESIGNEE AND PROVIDE COPIES OF THE INSTITUTE'S ANNUAL REPORT TO THE GOVERNOR OF THE STATE OF FLORIDA, THE CABINET, THE PRESIDENT OF THE SENATE, THE SPEAKER OF THE HOUSE AND THE CHAIR OF THE BOARD OF GOVERNORS. ALTHOUGH THE CORPORATION IS A PRIVATE ENTITY, IT IS NONETHELESS SUBJECT TO THE STATE OF FLORIDA'S PUBLIC RECORDS AND THE PUBLIC MEETINGS LAWS. THE CORPORATION ALSO RELIES ON ANNUAL APPROPRIATIONS BY THE LEGISLATURE OF THE STATE OF FLORIDA AND GRANTS FROM VARIOUS LOCAL, STATE AND FEDERAL AGENCIES FOR OPERATION AND MAINTENANCE OF ITS FACILITIES AND FOR SPECIFIC RESEARCH AND CLINICAL PROGRAMS. FOR THESE REASONS, THE CORPORATION FROM TIME TO TIME ENGAGES LOBBYISTS AND OTHER CONSULTANTS; (1) TO ASSIST IT IN COMPLYING WITH ITS REPORTING REQUIREMENTS TO THE STATE OF FLORIDA UNDER SECTION 1004.43, FLORIDA STATUTES; (2) TO MONITOR LEGISLATIVE AND EXECUTIVE BRANCH ACTION AT LOCAL, STATE AND FEDERAL LEVELS OF GOVERNMENT WHICH IMPACT ITS OPERATION AND THE FULFILLMENT OF ITS MISSION; AND (3) TO INFLUENCE LEGISLATION IN FURTHERANCE OF ITS MISSION IN THE AREAS OF CANCER RESEARCH AND TREATMENT, THE TEACHING AND TRAINING OF HEALTH CARE PROFESSIONALS AND COMMUNITY EDUCATION AND OUTREACH ACTIVITIES. THE CORPORATION DOES NOT ENGAGE IN ANY ACTIVITIES TO SUPPORT OR OPPOSE ANY CANDIDATE FOR PUBLIC OFFICE. PART II-B, LINE 1I, OTHER ACTIVITIES THE OTHER ACTIVITIES AMOUNT LISTED ON LINE 1I IS COMPRISED OF EXPENSES RELATED TO ORCHESTRATING CONTACT BETWEEN GRASSROOTS SUPPORTERS (WHO ARE VOLUNTEERS) AND ELECTED OFFICIALS TO PROMOTE THE INSTITUTION'S LEGISLATIVE OBJECTIVES. 18106905 18106905 458450863 180484451 277966412 8831338 4414722 4416616 256147489 203684593 52462896 25164569 25164569 378117398 INTEREST IN NET ASSETS OF FOUNDATION 41762444 ASSETS WHOSE USE IS LIMITED 215983122 RECEIVABLES FROM CONTROLLED ORGS 8235952 OTHER RECEIVABLES 8431104 OTHER ASSETS 69617 274482239 LEASE OBLIGATIONS 5828206 OTHER LIABILITIES 1798923 7627129 X PART X, LINE 2: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: THE CANCER CENTER RECOGNIZES A TAX POSITION AFTER DETERMINING THAT A RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT (GREATER THAN 50% LIKELIHOOD) SUSTAIN THE POSITION FOLLOWING AN AUDIT AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED, ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. 1 AMERICAN ASSOC FOR CANCER 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 236251648 501(C)(3) 10000 SPONSORSHIP AMERICAN CANCER SOCIETY INC 250 WILLIAMS STREET NW SUITE 400 ATLANTA GA 30303 131788491 501(C)(3) 22500 SPONSORSHIP AUSTIN HEALTH 145 STUDLEY ROAD HEIDELBERG VIC AS 3084 7535 SPONSORSHIP BEST PROGRAM 10006 CROSS CREEK BLVD TAMPA FL 33647 202834380 501(C)(3) 5500 SPONSORSHIP COPPERHEAD CHARITIES 36750 US 19 N PALM HARBOR FL 34684 592319162 501(C)(3) 7750 SPONSORSHIP DEBARTOLO FAMILY FOUNDATION INC 15436 N FLORIDA AVENUE SUITE 200 TAMPA FL 33613 311739677 501(C)(3) 10000 SPONSORSHIP GREATER TAMPA CHAMBER OF COMMERCE INC 201 N FRANKLIN STREET SUITE 201 TAMPA FL 33602 590474960 501(C)(6) 11500 SPONSORSHIP HILLSBOROUGH EDUCATION FOUNDATION INC 2306 N HOWARD AVENUE TAMPA FL 33607 592883361 501(C)(3) 50000 SPONSORSHIP KAY YOW CANCER FUND 5121 KINGDOM WAY SUITE 305 RALEIGH NC 27607 261789695 501(C)(3) 15000 SPONSORSHIP MORTON PLANT MEASE HC 1200 DRUID ROAD SOUTH CLEARWATER FL 33756 591751535 501(C)(3) 15000 SPONSORSHIP PAUL ANTHONY LIVE LIF 1525 GOLF RULES CT EAST STROUDSBURG PA 18302 454465001 501(C)(3) 30000 SPONSORSHIP PEDIATRIC CANCER FOUNDATION 5500 W EXECUTIVE DRIVE SUITE 300 TAMPA FL 33609 593097333 501(C)(3) 20000 SPONSORSHIP TAMPA HILLSBOROUGH ECONOMIC DEVEL CORP 101 E KENNEDY BLVD SUITE 1750 TAMPA FL 33602 271010441 501(C)(6) 26000 SPONSORSHIP TAMPA INNOVATION ALLIANCE INC 3100 E FLETCHER AVENUE TAMPA FL 33613 611692291 501(C)(6) 150000 SPONSORSHIP THE V FOUNDATION 106 TOWERVIEW COURT CARY NC 27513 133705951 501(C)(3) 25000 SPONSORSHIP H LEE MOFFITT CC&RI HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501(C)(3) 97983 INTERCOMPANY SUPPORT M2GEN CORP 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 281538 INTERCOMPANY SUPPORT 12 5 PART I, LINE 2: THE SCHEDULE I, PART II, GRANTS LISTED AS SPONSORSHIPS ARE APPROVED THROUGH THE CHECK REQUEST PROCESS. BECAUSE OF THE NATURE OF THE GRANTS, THE GRANT USE IS NOT MONITORED SINCE THEY ARE GIVEN TO THE ORGANIZATION FOR A SPECIFIC PURPOSE OR EVENT. THE GRANTS LISTED AS INTERCOMPANY SUPPORT ARE ONLY MADE TO RELATED ORGANIZATIONS TO SUPPORT THEIR OPERATIONS. X 0 1 X X X X 0 1 0 0 0 1 1 0 0 ALAN F LIST PRES/CEO 817983 0 357679 0 218085 0 111924 0 39115 0 1544786 0 91783 0 LOUIS D DE LA PARTE EVP GEN COUNS & ASST SEC 412753 0 136072 0 34582 0 95939 0 31938 0 711284 0 30320 0 JOHN A KOLOSKY EVP COO 609598 0 200933 0 100194 0 190965 0 24975 0 1126665 0 56709 0 G DOUGLAS LETSON EVP-PIC 0 559553 0 183891 0 52293 0 74446 0 28962 0 899145 0 49047 THOMAS A SELLERS EVP CNT DIR, DIR-MRI 561862 0 184595 0 65884 0 109488 0 30419 0 952248 0 49736 0 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREAS 466721 0 150262 0 44453 0 57828 0 22693 0 741957 0 34297 0 LYNN C MOSCINSKI CHIEF ACADEMIC OFFICER 0 494298 0 53297 0 16158 0 67839 0 25763 0 657355 0 0 MARIANA BUGALLO-MUROS VP CHIEF HR OFFICER 292872 0 80955 0 11557 0 21286 0 31044 0 437714 0 0 0 DONALD FUTRELL VP FACILITIES & SUPPORT SV 231655 0 64882 0 5349 0 21958 0 27691 0 351535 0 0 0 B LEE GREEN VP DIVERSITY, PR & STRAT COMM 254356 0 71504 0 30460 0 37968 0 35075 0 429363 0 12938 0 JENNIFER GREENMAN VP & CIO 260249 0 71370 0 6657 0 37100 0 26111 0 401487 0 0 0 DIANE HAMMON VP STRATEGIC DEVELOPMENT 253226 0 70158 0 1606 0 40905 0 33627 0 399522 0 0 0 TRACY N PETERSON VP DEPUTY GENERAL COUNSEL 218079 0 62233 0 497 0 23950 0 36467 0 341226 0 0 0 DANA E ROLLISON VP CHIO 264069 0 80713 0 12127 0 53765 0 21402 0 432076 0 6138 0 BRIAN SPRINGER VP RESEARCH ADMIN 294088 0 88783 0 1391 0 23229 0 24532 0 432023 0 0 0 W J WILSON VP GOVT RELATIONS 251299 0 68878 0 19980 0 54449 0 22489 0 417095 0 0 0 KAREN FIELDS MED DIR, STRATEGIC ALLIANC 115775 0 39922 0 1730 0 4675 0 7181 0 169283 0 0 0 JOHN L CLEVELAND ACD BASIC SCIENCE NFGC 358329 0 110600 0 4337 0 22224 0 30005 0 525495 0 0 0 JULIE Y DJEU ACD RESEARCH EDUCATION 303128 0 91525 0 13592 0 49706 0 16915 0 474866 0 7136 0 ROBERT J GILLIES PL CHAIR RSCH BASIC SCIENCE-IMAGING 330996 0 80367 0 6240 0 57763 0 22453 0 497819 0 1250 0 SAID M SEBTI PL CHAIR RSCH BASIC SCIENCE-DRUG DIS 370514 0 11218 0 4091 0 51419 0 17334 0 454576 0 0 0 DORTE HEIMBECK FORMER INT VP HR 165202 0 21153 0 518 0 25115 0 11063 0 223051 0 0 0 JAMES J MULAY FORMER EVP APPL SC & ACD T 383285 0 117488 0 38718 0 33073 0 27654 0 600218 0 24320 0 DANIEL M SULLIVAN FORMER EVP ACD CLINICAL IN 0 444260 0 133486 0 36022 0 61813 0 19046 0 694627 0 31041 WILLIAM S DALTON FORMER PRES-CEO;CTR DIR TO 0 642212 0 85000 0 26968 0 41868 0 27908 0 823956 0 0 PART I, LINE 1B PAYMENTS MADE FOR SOCIAL CLUB DUES ARE APPROVED BY THE JOINT EXECUTIVE COMPENSATION AND BENEFITS COMMITTEE (JEC&BC). PAYMENTS ARE A FIXED AMOUNT BASED ON JOB CLASSIFICATION AND IS DOCUMENTED IN MINUTES OF THE COMMITTEE AND REPORTED BACK TO THE BOARD. PART I, LINE 4B TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON LCS'S 2016 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2016 FROM THE PLAN: YVETTE M. LYONS TREMONTI-$34,297 JOHN A. KOLOSKY-$56,709 LOUIS D. DE LA PARTE-$30,320 G. DOUGLAS LETSON-$49,047 B. LEE GREEN-$12,938 ALAN F. LIST-$91,783 JAMES J. MULAY-$24,320 THOMAS A. SELLERS-$49,736 W. J. WILSON-$0 DANIEL M. SULLIVAN-$31,041 MARIA BUGALLO-MUROS-$0 DANA ROLLISON-$6,138 JULIE DJEU-$7,136 DIANE HAMMON-$0 ROBERT J. GILLIES-$1,250 JOHN CLEVELAND-$0 KAREN FIELDS-$0 DONALD FUTRELL-$0 JENNIFER GREENMAN-$0 TRACY NICOLE PETERSON-$0 SAID SEBTI-$0 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON A PERCENTAGE OF MOFFITT'S NET OPERATING INCOME AND ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS, DIVISIONAL AND/OR INDIVIDUAL GOALS, PROVIDED A CERTAIN NET OPERATING INCOME THRESHOLD IS MET. A CITY OF TAMPA 591101138 875161CE9 2016-11-03 93832926 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 B HILLSBOROUGH CTY INDUSTRIAL DEV AUTHORITY 591293512 2015-10-06 9750000 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 C CITY OF TAMPA 591101138 875161BN0 2012-11-29 39972900 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 D CITY OF TAMPA 591101138 875282BE4 2012-09-19 144692131 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 A 93833226 92778972 1054254 2010 0 1 1 1 B 9754102 9754102 2010 1 0 1 1 C 6115000 39973753 39689030 284723 2012 1 0 1 1 D 14150000 145362940 17913907 1176163 104287010 21985860 2016 1 0 0 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 B 0 1 1 1 0 0.00000 0.00000 0.00000 0 0 1 D 0 1 1 1 0 0.00000 0.00000 0.00000 0 0 1 A 0 0 0 1 0 0 0 0 1 B 0 0 0 1 1 0 0 0 1 C 0 0 0 1 0 0 0 0 1 D 0 0 0 1 0 0 0 0 1 A 1 B 1 C 1 D 1 FORM 990, SCHEDULE K, PART IA COLUMN (F) SERIES 2016B IS AN ADVANCE REFUNDING ON SERIES 2007A WHICH WAS USED TO: 1) FINANCE THE COST OF CONSTRUCTION AND EQUIPPING A FOUR STORY ADDITION TO THE MAIN CAMPUS OF THE HOSPITAL, TO INCLUDE 36 ADDITIONAL INPATIENT BEDS, RADIATION ONCOLOGY CLINIC PROGRAM EXPANSION WITH THE ADDITION OF TWO NEW VAULTS USED FOR STATE OF THE ART LINEAR ACCELERATORS, CLINICAL LAB AND PATHOLGY PROGRAM EXPANSION, APPROXIMATELY 40,000 GROSS SQUARE FEET OF FACULTY OFFICE SPACE, AND 1,000 SPACE PARKING GARAGE. 2) FINANCE THE COST OF VARIOUS BACKFILL AND REFURBISHMENT PROJECTS, INCLUDING THE ADDITION OF EIGHT INPATIENT BEDS IN EXISTING SPACE LOCATED AT THE INSTITUTE AND HOSPITAL. FORM 990, SCHEDULE K, PART IB COLUMN (F) REPLACEMENT BONDS WERE ISSUED FOR SERIES 2010A WHICH WERE USED FOR: 1)PAYING ALL OR A PORTION OF THE COST OF IMPROVEMENT, BUILD-OUT AND EQUIPPING OF CERTAIN CAPITAL IMPROVEMENTS LOCATED AT MOFFITT INTERNATIONAL PLAZA,(MIP), PROJECT SITE AND THE ACQUISITION OF EQUIPMENT, INCLUDING, WITHOUT LIMITATION, THE IMPROVEMENT, BUILD-OUT, DESIGN, RENOVATION AND EQUIPPING OF A CANCER TREATMENT AND IMAGING CENTER TO BE LOCATED AT MIP; 2)FINANCING AND REFINANCING CERTAIN OTHER CAPITAL COSTS PREVIOUSLY INCURRED BY THE HOSPITAL WITH RESPECT TO SUCH PROJECTS. FORM 990, SCHEDULE K, PART IC COLUMN (F) 1)PROCEEDS USED TO CURRENT REFUND SERIES 1999A AND 2002C BONDS, ISSUED MARCH 25, 1999 AND NOVEMBER 14, 2002 RESPECTIVELY. FORM 990, SCHEDULE K, PART ID COLUMN (F) 1) ACQUISITION, CONSTRUCTION, FURNISHING AND EQUIPPING OF THE MULTI-STORY MCKINLEY CLINICAL RESEARCH FACILITY AND INFRASTRUCTURE THAT WILL CONTAIN AN AMBULATORY SURGERY CENTER, PROCEDURE SUITES, CLINICS, IMAGING, INFUSION, SCREENING AND DRY LAB RESEARCH. 2)CONSTRUCTION, RENOVATION, AND EQUIPPING CLINICAL AND RESEARCH FACILITIES INCLUDING ADDITIONAL BED CAPACITY, OPERATING SUITES AND ASSOCIATED FACILITIES AND INFRASTRUCTURE. 3) A PORTION OF THE 2012A PROCEEDS WAS USED TO CURRENT REFUND 2002A AND 2002B SERIES BONDS, BOTH ISSUED NOVEMBER 14, 2002. FORM 990, SCHEDULE K, PART IE COLUMN (F) PROCEEDS OF THE 2016A BOND ISSUANCE WILL BE USED TO PURCHASE LAND AND BUILDING ON USF CAMPUS AND AN ADDITIONAL MCKINLEY CAMPUS SITE FOR CONSTRUCTION OF RESEARCH AND RESEARCH SUPPORT FACILITIES, CLINICAL AND RESEARCH SUPPORT OFFICES, THE RELOCATION OF CHILD DEVELOPMENT CENTER, AND THE CONSTRUCTION OF RESEARCH LABS. FORM 990, SCHEDULE K, PART IF COLUMN (F) REPLACEMENT BONDS WERE ISSUED IN TWO PARTS FOR SERIES 2010A WHICH WERE USED FOR: 1)PAYING ALL OR A PORTION OF THE COST OF IMPROVEMENT, BUILD-OUT AND EQUIPPING OF CERTAIN CAPITAL IMPROVEMENTS LOCATED AT MOFFITT INTERNATIONAL PLAZA,(MIP), PROJECT SITE AND THE ACQUISITION OF EQUIPMENT, INCLUDING, WITHOUT LIMITATION, THE IMPROVEMENT, BUILD-OUT, DESIGN, RENOVATION AND EQUIPPING OF A CANCER TREATMENT AND IMAGING CENTER TO BE LOCATED AT MIP; 2)FINANCING AND REFINANCING CERTAIN OTHER CAPITAL COSTS PREVIOUSLY INCURRED BY THE HOSPITAL WITH RESPECT TO SUCH PROJECTS. FORM 990, SCHEDULE K PART II, LINE 3 THE DIFFERENCE BETWEEN TOTAL PROCEEDS AND ISSUANCE PRICE IS INVESTMENT EARNINGS. SCHEDULE K, PART IV, LINE 2C: MOFFITT CONTRACTS WITH THIRD PARTY TO ANNUALLY CALCULATE ARBITRAGE REBATES. NO REBATES ARE DUE. A CITY OF TAMPA 591101138 875146AQ5 2016-11-16 58742390 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 B HILLSBOROUGH CTY INDUSTRIAL DEV AUTHORITY 591293512 2015-10-22 8690000 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 A 58909995 594871 1252650 57062474 0 0 0 1 B 8693656 8693656 2010 1 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 B 0 1 1 1 0 0.00000 0.00000 0.00000 0 0 1 A 0 0 0 1 0 0 0 0 1 B 0 0 0 1 1 0 0 0 1 A 1 B 1 SENATOR CONNIE MACK SEE PART V 81250 SEE PART V 0 FORM 990, SCHEDULE L, PART IV INTERESTED PERSON: SENATOR CONNIE MACKRELATIONSHIP: PARTNER AND SENIOR POLICY ADVISOR WITH LIBERTY PARTNERS, GROUP, A CONSULTING PUBLIC POLICY FIRM THAT PERFORMED SERVICES FOR THE INSTITUTE IN FY2017 IN THE AMOUNT OF $81,250. X EQUIPMENT 71 1589843 PURCHASE PRICE 0 0 0 0 PART I, COLUMN (B): THE NUMBER ON LINE 25(B) REPRESENTS THE NUMBER OF CONTRIBUTIONS, NOT THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON THE INSTITUTE AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. INSTITUTE & M2GEN, CORP.: THEODORE J. COUCH, DIRECTOR & OFFICER SENATOR CONNIE MACK, DIRECTOR & OFFICER ROBERT ROTHMAN, DIRECTOR & OFFICER H. LEE MOFFITT, DIRECTOR LOUIS D. DE LA PARTE, OFFICER JOHN A KOLOSKY, OFFICER YVETTE LYONS TREMONTI, OFFICER INSTITUTE & MOFFITT TECHNOLOGIES CORPORATION: ALAN F. LIST, DIRECTOR AND OFFICER JOHN A. KOLOSKY, OFFICER LOUIS D. DE LA PARTE, OFFICER YVETTE LYONS TREMONTI, OFFICER FORM 990, PART VI, SECTION B, LINE 11B LINE 11B, PRIOR TO PROVIDING FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, TO THE PARENT-RESEARCH BOARD OF DIRECTORS FOR REVIEW, THE CHIEF FINANCIAL OFFICER REVIEWS THE RETURN. SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED AND ANY NECESSARY CORRECTIONS ARE MADE. PRIOR TO ELECTRONICALLY FILING FORM 990, MOFFITT PARENT-RESEARCH PROVIDES A COPY OF THE RETURN TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS A PRESENTATION IS MADE TO RESEARCH BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 MOFFITT'S BOARD OF DIRECTORS HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDES THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. FORM 990, PART VI, SECTION C, LINE 19 MOFFITT RESEARCH MAKES AVAILABLE TO THE PUBLIC THROUGH THIRD PARTY VENDORS' WEBSITES, ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS. FORM 990 IS MADE AVAILABLE ON GUIDESTAR WHILE THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON DACBOND. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VI, SECTION B, LINE 16B: THE ORGANIZATION HAS ADOPTED A WRITTEN JOINT VENTURE PROCEDURE WITH WHICH IT COMPLIES, BUT HAS NOT BEEN BOARD APPROVED. PARENT/RESEARCH HAS ONE JOINT VENTURE AGREEMENT WITH PREMIER PURCHASING PARTNERS WHICH HAS BEEN IN EFFECT PRIOR TO 2008 AND RENEWED AT THE END OF 2014. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 443,719. MANAGEMENT AND GENERAL EXPENSES 1,182,084. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,625,803. FACULTY FEES AND COLLECTION EXPENSES: PROGRAM SERVICE EXPENSES 899,808. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 899,808. PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 6,966,664. MANAGEMENT AND GENERAL EXPENSES 9,981,940. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 16,948,604. FORM 990, PART IX, COLUMN (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE THE CONTRIBUTIONS ARE FROM RELATED ORGANIZATIONS, GOVERNMENT GRANTS, AND OTHER GRANTS. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. FORM 990, PART XI, LINE 9: PREMIER PARTNERSHIP INCOME -38,963. CHANGE IN INTEREST IN NET ASSETS OF FOUNDATION 8,560,534. TRANSFER FROM TAX EXEMPT AFFILIATE 67,992,207. GRANT REFUNDS -279,525. LOSS FROM EARLY EXTINGUISHMENT OF DEBT -2,718,364. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 N/A 1 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CANCER CTR & RES INST INC 1 H LEE MOFFITT CC&RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(C)(3) LINE 10 H LEE MOFFITT CANCER CTR & RES INST INC 1 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CC&RI INC C -1305 263199 1.00000 1 M2GEN CORP 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL H LEE MOFFITT CC&RI INC C 7442156 34359371 0.75000 1 1 1 1 1 0 0 0 0 0 0 0 1 1 1 0 1 0 0 0 M2GEN CORP A 226922 FMV M2GEN CORP A 260814 FMV M2GEN CORP B 281538 FMV H LEE MOFFITT CC&RI HOSPITAL INC B 97983 FMV H LEE MOFFITT CC&RI HOSPITAL INC C 3720000 FMV H LEE MOFFITT CC&RI FOUNDATION INC C 12869514 FMV M2GEN CORP C 3157055 FMV H LEE MOFFITT CC&RI FOUNDATION INC P 7338574 FMV M2GEN CORP P 875157 FMV M2GEN CORP D 18564744 FMV M2GEN CORP L 22221 FMV M2GEN CORP L 1721043 FMV